Sponsor Dossier
Glenmark Pharmaceuticals
Sponsor Dossier for Glenmark Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABIRATERONE VIATRIS
- Brand: ARABITRO
- Brand: ATOVACUE
- Brand: BORTRACZO
- Brand: DOFIDAZ
- Brand: GLENMARK
- Brand: GLENMECT
- Brand: HILKOTA
About
Glenmark Pharmaceuticals is an Australian Private Company with ABN 23116922500, registered in New South Wales. The entity status is Active.
Portfolio
Glenmark Pharmaceuticals has 11 brands on the ARTG, of which 7 are indexable and 5 carry a Product Information document. 7 brands are PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include ABIRATERONE VIATRIS, ARABITRO, ATOVACUE, BORTRACZO, DOFIDAZ, GLENMARK, GLENMECT, HILKOTA, SIBZEOS, SUPIROCIN, TRANAMEF.
Therapeutic focus
— Dermatology: 5 brands — Oncology: 3 brands — Infectious Disease: 2 brands — Psychiatry: 1 brand
PBS footprint
7 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.